SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines

Certain aspects of the immunogenicity and effectiveness of the messenger ribonucleic acid (mRNA) vaccines (mRNA-1273 and BNT162b2) developed in response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic are still uncharacterized. Serum or plasma samples from healthy donor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickey, Thomas E., Kemp, Troy J., Bullock, Jimmie, Bouk, Aaron, Metz, Jordan, Neish, Abigail, Cherry, James, Lowy, Douglas R., Pinto, Ligia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronavirus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305493/
https://www.ncbi.nlm.nih.gov/pubmed/37264688
http://dx.doi.org/10.1080/21645515.2023.2215677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305493/
https://www.ncbi.nlm.nih.gov/pubmed/37264688
http://dx.doi.org/10.1080/21645515.2023.2215677

Ejemplares similares